Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

CWZ, Nijmegen

Mount Sinai Faculty Practice Associates, New York

Montefiore Hospital, The Bronx

Queens Hospital Center (QHC - Queens Cancer Center, Jamaica

Stony Brook University, Stony Brook

MidLantic Urology, Philadelphia

Chesapeake Urology Research Associates, Towson

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore

University of Virginia - Health Science Center, Charlottesville

Virginia Oncology Associates, Norfolk

Duke University Medical Center, Durham

Emory University Hospital, Atlanta

Northside Hospital, Austell

University of Alabama at Birmingham, Birmingham

University Hospitals Cleveland Medical Center, Cleveland

Cleveland Clinic, Cleveland

University of Michigan Ann Arbor, Ann Arbor

Karmanos Cancer Institute, Detroit

Loyola University Medical Center, Maywood

Northshore University HealthSystem, Evanston

Washington University School of Medicine, St Louis

MD Anderson Hospital, Houston

Urology San Antonio, San Antonio

Tower Urology, Los Angeles

John Wayne Cancer Institute, Santa Monica

University of California Irvine Medical Center (UCIMC), Orange

Turku University Hospital, Turku

Maxima MC, Veldhoven